Severe Dysphagia is Rare After Magnetic Sphincter Augmentation
Open Access
- 29 April 2022
- journal article
- research article
- Published by Wiley in World Journal of Surgery
- Vol. 46 (9) , 2243-2250
Abstract
Background: Dysphagia remains the most significant concern after anti‐reflux surgery, including magnetic sphincter augmentation (MSA). The aim of this study was to evaluate postoperative dysphagia rates, its risk factors, and management after MSA.Methods: From a prospectively collected database of all 357 patients that underwent MSA at our institution, a total of 268 patients were included in our retrospective study. Postoperative dysphagia score, gastrointestinal symptoms, proton pump inhibitor intake, GERD‐HRQL, Alimentary Satisfaction, and serial contrast swallow imaging were evaluated within standardized follow‐up appointments. To determine patients’ characteristics and surgical factors associated with postoperative dysphagia, a multivariable logistic regression analysis was performed.Results: At a median follow‐up of 23 months, none of the patients presented with severe dysphagia, defined as the inability to swallow solids or/and liquids. 1% of the patients underwent endoscopic dilatation, and 1% had been treated conservatively for dysphagia. 2% of the patients needed re‐operation, most commonly due to recurrent hiatal hernia. Two patients underwent device removal due to unspecific discomfort and pain. No migration of the device or erosion by the device was seen. The LINX® device size ≤ 13 was found to be the only factor associated with postoperative dysphagia (OR 5.90 (95% CI 1.4–24.8)). The postoperative total GERD‐HRQL score was significantly lower than preoperative total score (2 vs. 19; p = 0.001), and daily heartburn, regurgitations, and respiratory complains improved in 228/241 (95%), 131/138 (95%) and 92/97 (95%) of patients, respectively.Conclusions: Dysphagia requiring endoscopic or surgical intervention was rare after MSA in a large case series. LINX® devices with a size < 13 were shown to be an independent risk factor for developing postoperative dysphagia.Keywords
Funding Information
- Medical University of Vienna
- Medizinische Universität Wien
This publication has 31 references indexed in Scilit:
- Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal RefluxClinical Gastroenterology and Hepatology, 2016
- Gastroesophageal reflux disease: A review of surgical decision makingWorld Journal of Gastrointestinal Surgery, 2016
- Laparoscopic Magnetic Sphincter Augmentation vs Laparoscopic Nissen Fundoplication: A Matched-Pair Analysis of 100 PatientsJournal of the American College of Surgeons, 2015
- Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux diseaseDiseases of the Esophagus, 2014
- One Hundred Consecutive Patients Treated with Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease: 6 Years of Clinical Experience from a Single CenterJournal of the American College of Surgeons, 2013
- LINX® Reflux Management System in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to refluxTherapeutic Advances in Gastroenterology, 2013
- Gastroesophageal Reflux Disease Treatment: Side Effects and Complications of FundoplicationClinical Gastroenterology and Hepatology, 2013
- Trends and perioperative outcomes of inpatient antireflux surgery in the United States, 1993-2006Diseases of the Esophagus, 2010
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagusGastrointestinal Endoscopy, 1995